FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

756211000001103: Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2115561000001110 Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2115571000001117 Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Is a Product containing precisely methyldopa 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Methyldopa false Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Methyldopa true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) 500 tablet Is pack of False Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) 1000 tablet Is pack of False Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) 1000 tablet Has AMP True Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) 500 tablet Has AMP True Methyldopa 250mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start